Rakovina Therapeutics Announces Q2 2026 Financial Results and Provides Corporate Update
Globe Newswire•31/08/2026•19:00 ET
0
Whiz Insights
All dollar amounts reflected in Canadian dollars unless otherwise stated.
VANCOUVER, British Columbia, Aug. 31, 2026 (GLOBE NEWSWIRE) -- Rakovina Therapeutics Inc. (TSX-V: RKV) (FSE: 7JO0), a biopharmaceutical company advancing innovative cancer therapies through AI-powered drug discovery, today announced its financial results for the three and six months ended June 30, 2026 (“Q2 2026” and “YTD 2026”, respectively), and provided an update on recent corporate developments.
Get started
Create a free account to read the full story.